Babiy, A V <br/><br/>
Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.  [electronic resource] 

 -  Biochemical pharmacology  Mar 1992 
 - 995-1000 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/0006-2952(92)90604-h  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Arteriosclerosis--etiology<br/>Diabetes Complications<br/>Diabetes Mellitus--blood<br/>Female<br/>Glycosylation<br/>Humans<br/>Lipid Peroxidation--drug effects<br/>Lipoproteins--blood<br/>Lipoproteins, HDL--blood<br/>Lipoproteins, LDL--blood<br/>Male<br/>Middle Aged<br/>Probucol--therapeutic use<br/>Vitamin E--analysis